Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02628873 · ClinicalTrials.gov registry record · NA
Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement
A NA study, sponsored by Wright State University.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02628873: Clinical Trial NA study, sponsored by Wright State University.
NCT02628873 is a NA study that was terminated before completion, run by Wright State University. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02628873, a NA study, was terminated before completion, sponsored by Wright State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The study evaluates whether saline infused sonography (SIS) with directed air bubbles for hysterosalpingo-contrast sonography (HyCoSy) is as good as or better than X-ray hysterosalpingography (HSG) for determining whether fallopian tubes are open or closed in patients who are undergoing an Essure confirmation test.
Primary Outcome
Observed flow of fluid/bubbles through fallopian tubes.
Interventions
- DEVICE HyCoSy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-10 |
| Phase | NA |
Why NCT02628873 stopped before completion
NCT02628873 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which HyCoSy is the first listed.
NCT02628873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02628873 about?
NCT02628873 is a clinical study titled "Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement". The study evaluates whether saline infused sonography (SIS) with directed air bubbles for hysterosalpingo-contrast sonography (HyCoSy) is as good as or better than X-ray hysterosalpingography (HSG) for determining whether fallopian tubes are open or closed in patients who are undergoing an Essure co...
What is the current status of trial NCT02628873?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2015-12. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02628873?
The interventions under investigation include: HyCoSy (DEVICE).
Who is sponsoring clinical trial NCT02628873?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02628873's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia